NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
64 hedge funds and large institutions have $33.2M invested in Niagen Bioscience, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
+6
Holders Change %
+10.34%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
17
Reduced
8
Closed
16
Calls
$280K
Puts
–
Net Calls
+$280K
Net Calls Change
-$105K
Top Buyers
1 |
BlackRock
New York
|
+$6.59M |
2 |
State Street
Boston,
Massachusetts
|
+$1.88M |
3 |
TCM
Tieton Capital Management
Yakima,
Washington
|
+$1.29M |
4 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
+$995K |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$898K |
Top Sellers
1 |
Millennium Management
New York
|
-$2.12M |
2 |
Goldman Sachs
New York
|
-$964K |
3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$751K |
4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$523K |
5 |
Invesco
Atlanta,
Georgia
|
-$417K |